Cannabist Company Holdings Inc (CBST) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.161x

Based on the latest financial reports, Cannabist Company Holdings Inc (CBST) has a cash flow conversion efficiency ratio of 0.161x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-24.59 Million ≈ $-17.79 Million USD) by net assets (CA$-152.95 Million ≈ $-110.64 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See CBST days of operational coverage to measure how many days the company can operate on defensive assets alone.

Cannabist Company Holdings Inc - Cash Flow Conversion Efficiency Trend (2018–2024)

This chart illustrates how Cannabist Company Holdings Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Cannabist Company Holdings Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Cannabist Company Holdings Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Biovica International AB (publ)
ST:BIOVIC-B
-0.670x
Medicon Hellas S.A.
AT:MEDIC
0.008x
Co-Diagnostics, Inc. Common Stock
NASDAQ:CODX
-0.489x
Baru Gold Corp
V:BARU
-0.166x
Sidomulyo Selaras Tbk
JK:SDMU
0.006x
Sri Adhikari Brothers Television Network Limited
NSE:SABTNL
-36.713x
AIM Commercial Growth Freehold And Leasehold Real Estate Investment Trust
BK:AIMCG
0.005x
Kintavar Exploration Inc
V:KTR
-0.021x

Annual Cash Flow Conversion Efficiency for Cannabist Company Holdings Inc (2018–2024)

The table below shows the annual cash flow conversion efficiency of Cannabist Company Holdings Inc from 2018 to 2024. For the full company profile with market capitalisation and key ratios, see CBST market cap overview.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CA$-30.06 Million
≈ $-21.74 Million
CA$-23.38 Million
≈ $-16.91 Million
0.778x +580.35%
2023-12-31 CA$65.35 Million
≈ $47.27 Million
CA$7.47 Million
≈ $5.40 Million
0.114x +122.10%
2022-12-31 CA$206.81 Million
≈ $149.60 Million
CA$-106.99 Million
≈ $-77.39 Million
-0.517x -54793.59%
2021-12-31 CA$550.08 Million
≈ $397.92 Million
CA$-518.40K
≈ $-375.00K
-0.001x +99.48%
2020-12-31 CA$286.95 Million
≈ $207.57 Million
CA$-52.27 Million
≈ $-37.81 Million
-0.182x +20.46%
2019-12-31 CA$266.93 Million
≈ $193.09 Million
CA$-61.13 Million
≈ $-44.22 Million
-0.229x +81.58%
2018-12-31 CA$-986.97K
≈ $-713.96K
CA$1.23 Million
≈ $887.68K
-1.243x --

About Cannabist Company Holdings Inc

NEO:CBST Canada Drug Manufacturers - Specialty & Generic
Market Cap
$12.41 Million
CA$17.15 Million CAD
Market Cap Rank
#26507 Global
#1082 in Canada
Share Price
CA$0.04
Change (1 day)
+0.00%
52-Week Range
CA$0.03 - CA$0.21
All Time High
CA$10.90
About

The Cannabist Company Holdings Inc. cultivates, manufactures, and sells cannabis products and related services for the medical and adult-use markets in the United States and internationally. The company operates medical and/or adult use marijuana businesses and dispensaries. It also offers flowers, concentrates, edibles, oils and tablets, and accessories under the dreamt, Seed & Strain, Triple Se… Read more